VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
RGC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
RGCRegencell Bioscience Holdings Limited
$5.27$2.6B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRGCQuarterly Balance Sheet

Regencell Bioscience Holdings Limited (RGC) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Regencell Bioscience Holdings Limited (RGC) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

RGC Balance Sheet

Quarterly statement

RGC Balance Sheet

Regencell Bioscience Holdings Limited (RGC) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ4'26Q2'26Q4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20
Total Current Assets14.22M2.36M4.9M6.59M8.11M9.83M11.62M14.19M16.44M16.44M66.85K305.96K386.98K243.31K
Cash & Short-Term Investments14.19M2.36M4.9M07.96M4.8M11.56M016.42M16.42M59.41K305.96K386.98K243.31K
Cash Only14.19M2.36M2.42M02.96M4.8M1.56M06.42M6.42M59.41K305.96K386.98K-243.31K
Short-Term Investments002.48M05M010M010M10M000486.61K
Accounts Receivable0000152.78K056.55K0007.44K000
Days Sales Outstanding--------------
Inventory000000-56.55K0-27.6K00000
Days Inventory Outstanding--------------
Other Current Assets30.7K05.8K6.59M05.03M014.19M00-7.44K000
Total Non-Current Assets506.4K656.17K852.77K892.74K324.2K642.42K1M1.36M1.57M1.57M273.29K294.42K127.04K-243.31K
Property, Plant & Equipment430.73K562.73K759.82K0226.51K0891.91K01.46M1.46M81.86K110.26K108.32K0
Fixed Asset Turnover---------1603.95x-----
Goodwill00000000000000
Intangible Assets00000000000000
Long-Term Investments00000000000000
Other Non-Current Assets75.67K93.44K92.95K892.74K97.68K642.42K108.5K1.36M114.3K114.3K191.42K184.16K18.72K-243.31K
Total Assets14.73M3.01M5.76M7.48M8.44M10.48M12.62M15.55M18.02M18.02M340.13K600.37K514.02K0
Asset Turnover---------129.96x-----
Asset Growth %155.92%-59.71%-31.79%-28.6%-33.15%-32.63%-29.95%-13.71%5197.59%2901.28%-33.83%---
Total Current Liabilities1.32M1.67M663.67K0193.58K0606.91K0577.76K577.76K4.34M3.59M3.16M0
Accounts Payable00000000000000
Days Payables Outstanding--------------
Short-Term Debt236.31K258.12K312.78K00000003.68M3.54M3.07M0
Deferred Revenue (Current)00000000000000
Other Current Liabilities1.08M1.41M350.89K00000000000
Current Ratio10.77x1.42x7.39x-41.92x-19.15x-28.46x28.46x0.02x0.09x0.12x-
Quick Ratio10.77x1.42x7.39x-41.92x-19.24x-28.51x28.46x0.02x0.09x0.12x-
Cash Conversion Cycle--------------
Total Non-Current Liabilities59.5K128.18K231.63K763.84K25.93K312.55K25.41K873.79K360.27K360.27K0000
Long-Term Debt00000000000000
Capital Lease Obligations59.5K128.18K231.63K025.93K025.41K0360.27K360.27K0000
Deferred Tax Liabilities00000000000000
Other Non-Current Liabilities000763.84K0312.55K0873.79K000000
Total Liabilities1.38M1.79M895.31K763.84K219.51K312.55K632.32K873.79K938.03K938.03K4.34M3.59M3.16M0
Total Debt295.81K386.3K544.41K085.74K0463.67K0771.25K771.25K3.68M3.54M3.07M0
Net Debt-13.9M-1.97M-1.87M0-2.88M-4.8M-1.1M0-5.65M-5.65M3.62M3.24M2.68M243.31K
Debt / Equity0.02x0.32x0.11x-0.01x-0.04x-0.05x0.05x----
Debt / EBITDA----0.54x---------
Net Debt / EBITDA-----18.20x-33.01x--------
Interest Coverage--------------
Total Equity13.35M1.22M4.86M6.72M8.22M10.16M11.99M14.66M17.08M17.08M-4M-2.98M-2.65M-1.84M
Equity Growth %174.66%-81.84%-40.86%-33.92%-31.45%-30.67%-29.81%-14.18%527.27%672.27%-50.8%-62.34%--
Book Value per Share0.030.000.010.010.020.020.020.030.030.03-0.01-0.01-0.01-0.00
Total Shareholders' Equity13.35M1.22M4.86M6.72M8.22M10.16M12.03M14.66M17.07M17.07M-4M-2.98M-2.65M-1.84M
Common Stock4.96K4.95K4.95K6.72M13010.16M13014.67K1301301001001000
Retained Earnings-36.9M-30.52M-25.2M0-21.62M0-17.32M0-11.44M-11.44M-4M-2.99M-2.65M0
Treasury Stock00000000000000
Accumulated OCI-45.26K-24.72K-64.79K0-45.77K0-86.66K0000-22.85K-9.52K-1.84M
Minority Interest000000-40.9K015.39K15.39K0000